Delivery Order SPE2DR25D1017-SPE2DR26F9CFN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription pharmaceutical product used in treating autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,154.12 and is scheduled for completion by December 31, 2025. The contract was awarded competitively with no set-aside designation, and performance will be executed from AmerisourceBergen's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, non-set-aside contract has a ceiling value of $67,903.44 with firm fixed pricing and is scheduled for completion by December 16, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mL, with a ceiling value of $1,591.96 and an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Humira (CF) Pen 40 mg/0.4 mL, a biological pharmaceutical used to treat autoimmune conditions. The contract is valued at $9,065.07 with a firm fixed price structure and an ultimate completion date of December 15, 2025. This is a non-set-aside award, indicating the contract was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,872.14 on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating autoimmune conditions. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical product, with a ceiling value of $5,024.93. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. The contract utilizes no set-aside designation, reflecting the contractor's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mL. This competitive, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 30, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $16,861.64, is scheduled for completion by December 31, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was awarded on a competitive basis without any set-aside designation,...
- The Defense Logistics Agency awarded a $25,129.87 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 23, 2025, with completion scheduled for December 24, 2025. This competitively awarded, firm fixed-price contract is unclassified and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,664.90 to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable pharmaceutical used to treat autoimmune conditions. This firm fixed-price delivery order is not set-aside and represents a competitively awarded contract with a completion date of December 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CFNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,328.55 and is scheduled for completion by December 31, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a critical federal vendor in the pharmaceutical distribution sector, AmerisourceBergen maintains a substantial portfolio of federal medical procurement contracts with DLA and other government healthcare systems, supporting defense and veteran healthcare supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/29/25 |